Répartition des phénotypes acétylateurs dans la population de MoscouLIL'IN, E. T; KORSUNSKAYA, M. P; MEKSIN, V. A et al.Genetika. 1983, Vol 19, Num 8, pp 1378-1380, issn 0016-6758Article

Acetylator phenotype in patients with lung carcinoma ― a negative reportBURGESS, E. J; TRAFFORD, J. A. P.European journal of respiratory diseases. 1985, Vol 67, Num 1, pp 17-19, issn 0106-4339Article

Acetylation phenotype in colorectal carcinomaILETT, K. F; DAVID, B. M; DETCHON, P et al.Cancer research (Baltimore). 1987, Vol 47, Num 5, pp 1466-1469, issn 0008-5472Article

Acetylator phenotypes: effect of ageGACHALYI, B; VAS, A; HAJOS, P et al.European journal of clinical pharmacology. 1984, Vol 26, Num 1, pp 43-45, issn 0031-6970Article

Répartition du phénotype acétylateur parmi des sujets normaux et alcooliques dans la population urbaine de MoscouLIL'IN, E. T; KORSUNSKAYA, M. P; MEKSIN, V. A et al.Genetika. 1984, Vol 20, Num 9, pp 1557-1559, issn 0016-6758Article

Ageing and acetylator phenotype as determined by administration of sulphadimidinePONTIROLI, A. E; DE PASQUA, A; BONISOLLI, L et al.European journal of clinical pharmacology. 1985, Vol 28, Num 4, pp 485-486, issn 0031-6970Article

High frequency of the rapid isoniazid acetylator phenotype in Lagos (Nigeria)ODEIGAH, P. G. C; OKUNOWO, M. A.Human heredity. 1989, Vol 39, Num 1, pp 26-31, issn 0001-5652, 6 p.Article

Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotypingNAIR, C. R; GUPTA, R. C; VARSHNEYA, A. K et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 12, pp 646-647, issn 0174-4879Article

Conséquences cliniques du polymorphisme génétique de la N-acetylation = Clinical significance of N-acétylation genetic polymorphismPRALONG, E; GASCON, M.-P; DAYER, P et al.Médecine et hygiène. 1986, Vol 44, Num 1653, pp 1162-1170, issn 0025-6749Article

Puissance d'acétylation de l'isoniazide et pigmentation dans la population blanche: incidences pratiques et perspectives embryologiques = Power of isoniazid's acetylation and pigmentation in white people. Useful incidences and embryological perspectivesLEPERCHEY, F; VIVIEN, J. N; VICAUT, E et al.Thérapie (Paris). 1983, Vol 38, Num 6, pp 613-620, issn 0040-5957Article

Acetylation phenotype in abstinent alcoholicsGUTHRIE, S. K; LANE, E. A; LINNOILA, M et al.Alcoholism, clinical and experimental research. 1989, Vol 13, Num 1, pp 66-68, issn 0145-6008Article

Inactivation de l'isoniazide chez l'enfant = Isoniazid inactivation in childrenPAIRE, M; LAVARENNE, J; RODET, M. F et al.Thérapie (Paris). 1984, Vol 39, Num 6, pp 625-631, issn 0040-5957Article

Evolutionarily conserved non-AUG translation initiation in NAT1/p97/DAP5 (EIF4G2)TAKAHASHI, Kazutoshi; MAMYAMA, Masayoshi; TOKUZAWA, Yoshimi et al.Genomics (San Diego, Calif.). 2005, Vol 85, Num 3, pp 360-371, issn 0888-7543, 12 p.Article

Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamsterHEIN, D. W; KIRLIN, W. G; FERGUSON, R. J et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 234, Num 2, pp 358-374, issn 0022-3565Article

Survey of the human acetylator polymorphism in spontaneous disordersEVANS, D. A. P.Journal of medical genetics. 1984, Vol 21, Num 4, pp 243-253, issn 0022-2593Article

Acetylator phenotype in patients with allergic diseases and its clinical significanceORZECHOWSKA-JUZWENKO, K; MILEJSKI, P; PATROWSKI, J et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1990, Vol 28, Num 10, pp 420-425, issn 0174-4879, 6 p.Article

Distribution of acetylator phenotype in relation to age and sex in Swedish patients: a retrospective studyPAULSEN, O; NILSSON, L. G.European journal of clinical pharmacology. 1985, Vol 28, Num 3, pp 311-315, issn 0031-6970Article

The association of the slow acetylator phenotype with bladder cancerEVANS, D. A. P; EZE, L. C; WHJBLEY, E. J et al.Journal of medical genetics. 1983, Vol 20, Num 5, pp 330-333, issn 0022-2593Article

Phénotype d'acétylation de la Sulfaméthazine, application à la surveillance du traitement antituberculeux = Acetylation of sulfamethazine. Application to antituberculous treatment monitoringZEIN, Y; MONGO, F; KHATIB, M et al.Provence médicale. 1983, Vol 51, Num 4-5, pp 63-67, issn 0755-2130Article

Caffeine as a metabolic probe : validation of its use for acetylator phenotypingBING-KOU TANG; KADAR, D; LI QIAN et al.Clinical pharmacology and therapeutics. 1991, Vol 49, Num 6, pp 648-657, issn 0009-9236Article

Kinetics of antipyrine and sulfamethazine in patients recovered from dihydralazine-hepatitisSIEGMUND, W; FRANKE, G; BAUMBARTEN, R et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1989, Vol 27, Num 4, pp 165-169, issn 0174-4879Article

Acetylator polymorphism in discoid lupus erythematosusLADERO, J. M; JIMENEZ, L. C; FERNANDEZ, M. J et al.European journal of clinical pharmacology. 1988, Vol 34, Num 3, pp 307-308, issn 0031-6970Article

A simple method for determining acetylator phenotype using isoniazidHUTCHINGS, A; ROUTLEDGE, P. A.British journal of clinical pharmacology. 1986, Vol 22, Num 3, pp 343-345, issn 0306-5251Article

Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritisPULLAR, T; HUNTER, J. A; CAPELL, H. A et al.Annals of the rheumatic diseases. 1985, Vol 44, Num 12, pp 831-837, issn 0003-4967Article

N-Acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk populationMOMMSEN, S; BARFOD, N. M; AAGAARD, J et al.Carcinogenesis (New York. Print). 1985, Vol 6, Num 2, pp 199-201, issn 0143-3334Article